Your browser doesn't support javascript.
loading
Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
Kosmidou, Ioanna; Shahim, Bahira; Dressler, Ovidiu; Redfors, Björn; Morice, Marie-Claude; Puskas, John D; Kandzari, David E; Karmpaliotis, Dimitri; Brown, W Morris; Lembo, Nicholas J; Banning, Adrian P; Kappetein, Arie Pieter; Serruys, Patrick W; Sabik, Joseph F; Stone, Gregg W.
Afiliación
  • Kosmidou I; Memorial Sloan Kettering Cancer Center, New York and Weill Cornell College of Medicine, New York, New York, USA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
  • Shahim B; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
  • Dressler O; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
  • Redfors B; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Morice MC; Hôpital privé Jacques Cartier, Ramsay Générale de Santé, Massy, France.
  • Puskas JD; Mount Sinai Heart at Mount Sinai Saint Luke's, New York, New York, USA.
  • Kandzari DE; Piedmont Heart Institute, Atlanta, Georgia, USA.
  • Karmpaliotis D; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Brown WM; Piedmont Heart Institute, Atlanta, Georgia, USA.
  • Lembo NJ; Memorial Sloan Kettering Cancer Center, New York and Weill Cornell College of Medicine, New York, New York, USA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.
  • Banning AP; John Radcliffe Hospital, Oxford, United Kingdom.
  • Kappetein AP; Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.
  • Serruys PW; Department of Cardiology, NUIG, National University of Ireland, Galway, Ireland; Imperial College of Science, Technology and Medicine, London, United Kingdom.
  • Sabik JF; Department of Surgery, UH Cleveland Medical Center, Cleveland, Ohio, USA.
  • Stone GW; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: gregg.stone@mountsinai.org.
J Am Coll Cardiol ; 83(11): 1073-1081, 2024 Mar 19.
Article en En | MEDLINE | ID: mdl-38479955
ABSTRACT

BACKGROUND:

The frequency of and relationship between hospital readmissions and outcomes after revascularization for left main coronary artery disease (LMCAD) are unknown.

OBJECTIVES:

The purpose of this study was to study the incidence, predictors, and clinical impact of readmissions following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for LMCAD.

METHODS:

In the EXCEL (XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial, 1,905 patients with LMCAD were randomized to PCI vs CABG. The cumulative incidence of readmissions was analyzed with multivariable Anderson-Gill and joint frailty models to account for recurrent events and the competing risk of death. The impact of readmission on subsequent mortality within 5-year follow-up was determined in a time-adjusted Cox proportional hazards model.

RESULTS:

Within 5 years, 1,868 readmissions occurred in 851 of 1,882 (45.2%) hospital survivors (2.2 ± 1.9 per patient with readmission[s], range 1-16), approximately one-half for cardiovascular causes and one-half for noncardiovascular causes (927 [49.6%] and 941 [50.4%], respectively). One or more readmissions occurred in 463 of 942 (48.6%) PCI patients vs 388 of 940 (41.8%) CABG patients (P = 0.003). After multivariable adjustment, PCI remained an independent predictor of readmission (adjusted HR 1.22; 95% CI 1.10-1.35; P < 0.0001), along with female sex, comorbidities, and the extent of CAD. Readmission was independently associated with subsequent all-cause death, with interaction testing indicating a higher risk after PCI than CABG (adjusted HR 5.72; 95% CI 3.42-9.55 vs adjusted HR 2.72; 95% CI 1.64-4.88, respectively; Pint = 0.03).

CONCLUSIONS:

In the EXCEL trial, readmissions during 5-year follow-up after revascularization for LMCAD were common and more frequent after PCI than CABG. Readmissions were associated with an increased risk of all-cause death, more so after PCI than with CABG.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Intervención Coronaria Percutánea Límite: Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Intervención Coronaria Percutánea Límite: Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos